博瑞傳播(600880.SH):旗下生學教育與華為在技術融合與創新等方面一直在推進深度合作
格隆匯11月28日丨博瑞傳播(600880.SH)在投資者互動平台表示,公司旗下生學教育與華為在技術融合與創新等方面一直在推進深度合作,生學教育與華為聯合打造的AI+身心安全解決方案已通過華為合作伙伴解決方案支持與服務中心測試驗證;同時也在探索人工智能在精準教學、心理健康、急救教育、校園安全等教育場景的應用,共創教育數字化產品,推進全國教育渠道共建共享。除此之外,公司在今年10月10日與百川智能簽署了《關於共建文化|教育大模型的合作協議》,雙方將充分發揮自身優勢、整合資源,在文化、教育與人工智能領域開展全方位合作,探索在文化和教育領域打造AI與實體經濟深度融合發展的標杆項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.